May 4, 2018 8:30am-2:30pm
In partnership with EY and Scientific American, Bioethics International is hosting a Forum on what it means to be a purpose driven, patient-centered and ethical pharma and health-innovation company.
Location: New York, NY
October 23, 2018 — October 24, 2018
The Milken Institute Future of Health Summit convenes thought leaders and decision makers to confront some of the world’s most significant health challenges.
Dr. Jennifer E. Miller, Founder of Bioethics International and Assistant Professor at Yale School of Medicine, will speak on the ethics and patient-centricity of healthcare innovation and the pharmaceutical sector.
November 11, 2018 — November 12, 2018
The World Economic Forum is made up of 38 councils, each with 20 experts from academia, government, NGOs and industry. The Future’s council is just one of the 38 councils. The two group chairs from each council attend the Davos meeting annually.
November 14, 2018 — November 15, 2018
Panel: Face-to-Face Meetings – the Formation of Meaningful Patient Relationships
Conduct patient advisory boards to give patients a voice in the drug production process in order that the product can meet their needs more effectively; Facilitate face-to-face meetings with patients to build trust and change their perception of pharma in a scalable way; Balance patient contribution with training to ensure they are empowered to contribute but with the right knowledge
Lydia Grossov, Patient Advocate
Katie Kolator, Associate Director Patient Marketing, Bristol-Myers Squibb
Joyce Chehade, Marketing Manager Hematology, CSL Behring
Jennifer Miller, Assistant Professor, Yale University School of Medicine
March 12, 2019 — March 14, 2019
Bioethics International and eyeforpharma will collaboratively draft a global code of ethics.
April 16, 2019 — April 17, 2019
At this event you can expect 700+ attendees who will come together to:
Put patients first by understanding pharma’s new value paradigm and embed it in your business
Unleash the power of data with smart data sourcing and analysis techniques from the smartest tech
Become the trusted partner by building real solutions through long-term collaborations based on trust and transparency
May 3, 2019 8:30am-2:30pm
In partnership with EY and Scientific American, Bioethics International is hosting its second annual Forum on what it means to be a purpose driven, patient-centered and ethical pharma and health-innovation company.
Location: New York, NY
October 2, 2018 — October 3, 2018
Measuring the impact of patient engagement helps ensure meaningful exchange and outcomes. This session presents a frank and forward looking discussion about the constraints around utilizing patient engagement metrics and new initiatives to advance the field
September 20, 2018 2:00-3:30pm
Public Accountability Around Disclosure
Merete Jørgensen, Senior Trial Disclosure Director, Clinical Reporting Anchor & Disclosure, Novo Nordisk, Denmark
Fiona Godlee, Editor in Chief, British Medical Journal (BMJ), United Kingdom
Jennifer Miller, Founder, Bioethics International and Good Pharma Scorecard, Assistant Professor, Yale University School of Medicine, United States of America
Lise Baltzer, Director for Global Publications, Novo Nordisk, Denmark
July 17, 2018 — July 18, 2018
These sessions will build on the strategies and tools discussed in the December 2017 Next Wave Forum – more details to come.
Location: Cambridge, MA
July 18, 2018 10:45-11:30am
This panel will discuss the impact of evolving technologies on cybersecurity as well as issues around privacy, quantum computing & encryption, big data, machine learning and AI.
Jonathan Conrad, Chairman, CEO & Founder, AdmieMobile
Shahryar Shaghagi, National Leader of Cybersecurity, CohnReznick
Jennifer Miller, Assistant Professor, Yale School of Medicine; Founder, Bioethics International
Mark Jackson, Scientific Lead, Cambridge Quantum Computing
June 27, 2018 9:00-10:00am
Blockchain technology offers many things. But if all you know about blockchain is bitcoin, you might be surprised to hear it may offer pharma an opportunity for more trustworthiness and transparency. In this free webinar we’ll be going beyond privacy, beyond honesty, beyond trust. We’ll explore how new technology and contract innovation offers a route for each and every human being to take control of their own data as their own property. And how pharma companies might welcome this development with open arms.
June 5, 2018 — June 6, 2018
DECONSTRUCTING CLINICAL TRIALS: the core of drug development and company valuations
Keywords: investment risks, opaque clinical trials.
Jennifer E. Miller, Founder, Bioethics International; Yale
Bowen Gu, Investor Engagement Researcher, Access to Medicine Foundation
Helena Fiestas, BNP Paribas Asset Management